tirzepatide fda indications Big update in pediatric diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA- approved for children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️ Tirzepatide vs. Retatrutide: Key Differences

This tachyphylaxis of gastric emptying is best documented for long-acting GLP-1 receptor agonists, where short-acting agents produce large, sustained emptying delays while long-acting agents produce an emptying delay that wanes with continued dosing

Check it weekly

Tirzepatide targets a second hormone, called glucose-dependent insulinotropic polypeptide, or GIP

The Oatmeal Ozempic trend started gaining traction on social media in early 2024, particularly on TikTok

People may seek out IV glutathione for its potential to brighten their complexion and to whiten skin

He pointed out, for instance, that there was less weight lost in semaglutide-treated patients in STEP-HFpEF DM than in STEP-HFpEF, but that the impact on HF outcomes was similar in both trials